What's going to turn this company around though? It's sperm...

What's going to turn this company around though? It's sperm technology is its only product, and it's no holy grail. It seems to be a long way from making money off it.

A bit too much hoping going on here. 90% of company directors have a lot of "skin in the game." Nusep is no different, and doesn't mean anything in terms of the company's success. That shouldn't be a feature of the company's future.

It's a bio company, so it won't take much to quickly build hype, but where will this hype come from? I think, traders are going to struggle, rightly or wrongly, to get on board considering Nuseps track record.